Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome

ConditionAcute Coronary Syndromes

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age18-65

SponsorKing Edward Medical University

About this trial

there will be 2 groups of patients with acute coronary syndrome. The patients will receive one of the 2 study drugs and impact on raising Vitamin D level will be seen after 6 months

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

Rosuvastatin 20 mg/day
Drug
Rosuvastatin 20 mg / Day for 24 weeks
Atorvastatin 40 mg
Drug
Atorvastatin 40mg / Day for 24 weeks

Treatment groups

152 Participants

are divided into 2 treatment groups

Group A: AtorvastatinActive comparator 1 intervention

Group B: RosuvastatinExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

Serum Vitamin D

Time frame

24 weeks

Secondary outcomes

Lipid Profile

Time frame

4 weeks & 24 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

King Edward Medical University

Lead sponsor

Source ClinicalTrials.gov

Apply now